Literature DB >> 32442401

Functional Genomics for Cancer Drug Target Discovery.

Benjamin Haley1, Filip Roudnicky2.   

Abstract

Functional genomics describes a field of biology that uses a range of approaches for assessing gene function with high-throughput molecular, genetic, and cellular technologies. The near limitless potential for applying these concepts to study the activities of all genetic loci has completely upended how today's cancer biologists tackle drug target discovery. We provide an overview of contemporary functional genomics platforms, highlighting areas of distinction and complementarity across technologies, so as to aid in the development or interpretation of cancer-focused screening efforts.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; RNAi; cancer; functional genomics; genetic screen; genome editing; oncology; transposon

Mesh:

Substances:

Year:  2020        PMID: 32442401     DOI: 10.1016/j.ccell.2020.04.006

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  6 in total

1.  Generation of Protein Inhibitors for Validation of Cancer Drug Targets Identified in Functional Genomic Screens.

Authors:  Sherin McDonald; Arunkumar Annan Sudarsan; Hanan Babeker; Kiranmayee Budharaju; Maruti Uppalapati
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Targeting pan-essential genes in cancer: Challenges and opportunities.

Authors:  Liang Chang; Paloma Ruiz; Takahiro Ito; William R Sellers
Journal:  Cancer Cell       Date:  2021-01-14       Impact factor: 31.743

3.  CRISPR screening of E3 ubiquitin ligases reveals Ring Finger Protein 185 as a novel tumor suppressor in glioblastoma repressed by promoter hypermethylation and miR-587.

Authors:  Kun Lin; Shang-Hang Shen; Feng Lu; Pengfeng Zheng; Shizhong Wu; Jingwei Liao; Xiaohang Jiang; Guangming Zeng
Journal:  J Transl Med       Date:  2022-02-19       Impact factor: 5.531

4.  CRISPR-surfaceome: An online tool for designing highly efficient sgRNAs targeting cell surface proteins.

Authors:  Hong Mei; Qian Gu; Wei Wang; Yu Meng; Lichun Jiang; Jia Liu
Journal:  Comput Struct Biotechnol J       Date:  2022-07-18       Impact factor: 6.155

Review 5.  Synthetic Lethality in Cancer Therapeutics: The Next Generation.

Authors:  Jeremy Setton; Michael Zinda; Nadeem Riaz; Daniel Durocher; Michal Zimmermann; Maria Koehler; Jorge S Reis-Filho; Simon N Powell
Journal:  Cancer Discov       Date:  2021-04-01       Impact factor: 39.397

6.  Cancer biology functional genomics: From small RNAs to big dreams.

Authors:  Soumya Sundara Rajan; Katelyn R Ludwig; Katherine L Hall; Tamara L Jones; Natasha J Caplen
Journal:  Mol Carcinog       Date:  2020-10-12       Impact factor: 5.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.